These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3513613)

  • 1. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action.
    Hansen I; Tsalikian E; Beaufrere B; Gerich J; Haymond M; Rizza R
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E269-73. PubMed ID: 3513613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization.
    Rizza RA; Mandarino LJ; Gerich JE
    Diabetes; 1982 Aug; 31(8 Pt 1):663-9. PubMed ID: 6761205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
    Rizza RA; Mandarino LJ; Gerich JE
    J Clin Endocrinol Metab; 1982 Jan; 54(1):131-8. PubMed ID: 7033265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in acromegaly: evaluation by studies of insulin binding to erythrocytes.
    Lerario AC; el-Andere W; Wajchenberg BL; Ohnuma LY; Rocha MH; Andriolo A
    J Endocrinol Invest; 1989 Mar; 12(3):155-61. PubMed ID: 2656831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
    Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemia.
    Muggeo M; Saviolakis GA; Businaro V; Valerio A; Moghetti P; Crepaldi G
    J Clin Endocrinol Metab; 1983 Apr; 56(4):733-8. PubMed ID: 6339536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral glucose metabolism in acromegaly.
    Foss MC; Saad MJ; Paccola GM; Paula FJ; Piccinato CE; Moreira AC
    J Clin Endocrinol Metab; 1991 May; 72(5):1048-53. PubMed ID: 2022706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin action in human adipose tissue in acromegaly.
    Bolinder J; Ostman J; Werner S; Arner P
    J Clin Invest; 1986 Apr; 77(4):1201-6. PubMed ID: 3514677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy metabolism and substrate oxidation in acromegaly.
    O'Sullivan AJ; Kelly JJ; Hoffman DM; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 1995 Feb; 80(2):486-91. PubMed ID: 7852509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in Cushing's syndrome.
    Nosadini R; Del Prato S; Tiengo A; Valerio A; Muggeo M; Opocher G; Mantero F; Duner E; Marescotti C; Mollo F; Belloni F
    J Clin Endocrinol Metab; 1983 Sep; 57(3):529-36. PubMed ID: 6348064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and Cardiac Hypertrophy in Acromegaly.
    Gurbulak S; Akin F; Yerlikaya E; Yaylali GF; Topsakal S; Tanriverdi H; Akdag B; Kaptanoglu B
    Adv Clin Exp Med; 2016; 25(3):449-55. PubMed ID: 27629732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response characteristics for effects of insulin on production and utilization of glucose in man.
    Rizza RA; Mandarino LJ; Gerich JE
    Am J Physiol; 1981 Jun; 240(6):E630-9. PubMed ID: 7018254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperproinsulinaemia in acromegaly: evidence for abnormal pancreatic beta-cell function?
    Gama R; Teale JD; Wright J; Ferns G; Marks V
    Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():627-31. PubMed ID: 9366999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
    Saad MJ; Moreira AC; Foss MC
    Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.
    Karlander S; Vranić M; Efendić S
    Diabetologia; 1986 Nov; 29(11):778-83. PubMed ID: 3817335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body insulin sensitivity rather than body-mass-index determines fasting and post-glucose-load growth hormone concentrations.
    Anderwald CH; Tura A; Gessl A; Smajis S; Bieglmayer C; Marculescu R; Luger A; Pacini G; Krebs M
    PLoS One; 2014; 9(12):e115184. PubMed ID: 25517727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.